Dainippon and Kyorin have formed an alliance for Aldose Reductase Inhibitor
December 5, 2002
Dainippon and Kyorin have formed an alliance for Aldose Reductase Inhibitor
Dainippon Pharmaceutical Co., Ltd. (President: Kenjiro Miyatake) and Kyorin Pharmaceutical Co., Ltd. (President: Ikuo Ogihara) jointly announced today that they signed a preliminary agreement related to AS-3201, an original aldose reductase inhibitor from Dainippon to treat diabetic complications.
Under the terms of the agreement, Dainippon and Kyorin aim to jointly develop AS-3201, with the intent to co-mark et the agent within Japan.
Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.